These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 6175556

  • 1. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
    Aya T.
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):587-96. PubMed ID: 6175556
    [Abstract] [Full Text] [Related]

  • 2. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T, Mizuno F, Osato T.
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [Abstract] [Full Text] [Related]

  • 3. Antibody-dependent autologous lymphocyte cytotoxicity against cells freshly transformed by Epstein-Barr virus.
    Aya T, Matsuo T, Takada K, Osato T, Mizuno F.
    IARC Sci Publ (1971); 1978 Aug; (24 Pt 2):711-9. PubMed ID: 221393
    [Abstract] [Full Text] [Related]

  • 4. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M.
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.
    Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978
    [Abstract] [Full Text] [Related]

  • 6. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 15; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, Lu SN, Liu HW.
    J Rheumatol; 2005 Jan 15; 32(1):44-7. PubMed ID: 15630723
    [Abstract] [Full Text] [Related]

  • 8. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K, Harada M, Sairenji T, Hinuma Y.
    J Immunol; 1980 Nov 15; 125(5):2112-7. PubMed ID: 6253564
    [Abstract] [Full Text] [Related]

  • 9. Analysis of cellular immune response to EBV by using cloned T cell lines.
    Slovin SF, Schooley RT, Thorley-Lawson DA.
    J Immunol; 1983 May 15; 130(5):2127-32. PubMed ID: 6187840
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC, Magrath IT, Balow JE.
    J Immunol; 1983 Oct 15; 131(4):1797-801. PubMed ID: 6311898
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.
    Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD.
    Cell Immunol; 2005 May 15; 235(1):29-38. PubMed ID: 16181618
    [Abstract] [Full Text] [Related]

  • 12. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G.
    Cancer Res; 1984 Mar 15; 44(3):1288-300. PubMed ID: 6318984
    [Abstract] [Full Text] [Related]

  • 13. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR, Wåhlin B, Andersson T, Perlmann P.
    J Immunol; 1984 Jun 15; 132(6):2760-6. PubMed ID: 6373918
    [Abstract] [Full Text] [Related]

  • 14. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
    Jondal M, Gunven P.
    Clin Exp Immunol; 1977 Jul 15; 29(1):11-5. PubMed ID: 70292
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
    Patel PC, Menezes J.
    Clin Exp Immunol; 1982 Jun 15; 48(3):589-601. PubMed ID: 6288292
    [Abstract] [Full Text] [Related]

  • 16. T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells.
    Tsoukas CD, Fox RI, Slovin SF, Carson DA, Pellegrino M, Fong S, Pasquali JL, Ferrone S, Kung P, Vaughan JH.
    J Immunol; 1981 May 15; 126(5):1742-6. PubMed ID: 6163816
    [Abstract] [Full Text] [Related]

  • 17. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S.
    J Clin Oncol; 2005 Dec 10; 23(35):8942-9. PubMed ID: 16204009
    [Abstract] [Full Text] [Related]

  • 18. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 10; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 19. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
    Thorley-Lawson DA.
    J Immunol; 1981 Mar 10; 126(3):829-33. PubMed ID: 6161964
    [Abstract] [Full Text] [Related]

  • 20. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.
    Jondal M.
    Clin Exp Immunol; 1977 Jul 10; 29(1):1-10. PubMed ID: 196801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.